다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
생명과학회지 = Journal of life science, v.19 no.1 = no.105, 2009년, pp.147 - 151
손민식 (경북대학교 생명식품공학부 및 대학원 나노과학기술과) , 서명선 (송광매원) , 이상한 (경북대학교 생명식품공학부 및 대학원 나노과학기술과)
AI-Helper
D-pinitol, another chemical structure of 3-O-methyl-D-chiro-inositol, is an important insulin-sensitizer. The purpose of this review is to examine the characteristics of pinitol and other analogs as functional food biomaterials which were well known to reduce blood glucose levels. Pinitol can be con...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Asplin, I., G. Galasko and J. Larner. 1993. Chiro-inositol deficiency and insulin resistance: A comparison of the chiroinositol and myo-inositon containing insulin mediators isolated from urine, hemo- dialysate, and muscle of control and type II diabetic subjects. Proc. Natl. Acad. Sci. USA 90, 5924-5928
Bates, S. H., R. B. Jones and C. J. Bailey. 2000. Insulin-like effect of pinitol. Br. J. Pharmacol. 130, 1944-1948
Buford, T. W., R. B. Kreider, J. R. Stout, M. Greenwood, B. Campbell, M. Spano, T. Ziegenfuss, H. Lopez, J. Landis and J. Antonio. 2007. Creatine supplementation and exercise. J. Int. Soc. Sports Nutr. 4, 6
Chun, S. H. 2004. Devlopment and therapeutic perspective of type 2 Diabetes Mellitus. Biochem. Mol. Biol. News 9, 204-219
Davis, A., M. Christiansen, J. F. Horowitz, S. Klein, M. K. Hellerstein, R. E. Ostlund Jr. 2000. Effect of pinitol treatment on insulin action in subjects with insulin resistance. Diabetes Care 23, 1000-1005
Farese, R. V., M. L. Standaert, K. Yamada, L. C. Huang, C. Zhang, D. R. Cooper, Z. Wang, Y. Yang, S. Suzuki, T. Toyota and J. Larner. 1994. Insulin-induced activation of glycerol-3-phosphate acyl- transferase by a chiro-inositol containing insulin mediator is defective in adipocytes of insulin-resistant, type II diabetic, Goto-Kakizaki rats. Proc. Natl. Acad. Sci. USA 91, 11040-11044
Fonteles, M. C., M. Q. Almeida and J. Larner. 2000. Antihyperglycemic effects of 3-O-methyl-D-chiro-inositol and D-chiro-inositol associated with managanese in streptozotocin diabetic rats. Horm. Metab. Res. 32, 129-132
Fontales, M. C., L. C. Huang and J. Larner. 1996. Infusion of pH 2.0 D-chiro-inositol glycan insulin putative mediator normalizes plasma glucose in streptozotocin diabetic rats at a dose equivalent to insulin without inducing hypoglycaemia. Diabetologia 39, 731-734
Gu, F., D. T. Nguyen, M. Stuible, N. Dube, M. L. Tremblay and E. Chevet. 2004. Protein-tyrosine phosphatase 1B potentiates IRE1 signaling during endoplasmic reticulum stress. J. Biol. Chem. 279, 49689-49693
Huang, L. C., M. C. M. C. Fonteles, D. B. Houston, C. Zhang and J. Larner. 1993. Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology 132, 652-657
Iuorno, M. J., D. J. Jakubowicz, J.-P. Patrice, P. Dillone, R. D. Gunn, G.. Allan and J. E. Nestler. 2002. Effects of D-chiro-inositol in lean women with the polycystic ovary syndrome. Endocrine Practice 8, 417-423
Jarret, L., E. H. A. Wong and J. A. Smith. 1985. Insulin mediator from rat skeletal muscle have differential effect on insulin-sensitive pathway of infact adipocytes. Science 227, 533-535
Kang, M. J., J. I. Kim, S. Y. Yoon, J. C. Kim and I. J. Cha. 2006. Pinitol from reduces postprandial blood glucose in patients with type 2 Diabetes Mellitus. J. Med. Food 9, 182-186
Kennington, A. S., C. R. Hill, J. Craig, C. Bogardus, I. Raz, H. K. Ortmeyer, B. C. Hansen, G. Romero and J. Larner. 1990. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. New Eng. J. Med. 323, 373-378
Kim, J. I., J. C. Kim, M. J. Kang, M. S. Lee, J. J. Kim and I. J. Cha. 2005. Effect of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study. Eur. J. Clin. Nutr. 59, 456-458
Kim, M. J., K. H. Yoo, H. S. Park, S. M. Jeong, C. J. Jin, Y. S. Choi and C. H. Jeong. 2005. Effect of pinitol on glucose metabolism and adipocytokines in uncontrolled type 2 Diabetes Mellitus. Diabetes 29, 344-351
Kipfer-Coudreau, S. D., Eberle, M. Sahbatou, A. Bonhomme, B. Guy-Grand, P. Froguel, P. Galan, A. Basdevant and K. Clement. 2004. Single nucleotide polymorphisms of protein tyrosine phosphatase 1B gene are associated with obesity in morbidly obese French subjects. Diabetologia 47, 1278-1284
Larner, J., L. C. Huang, C. F. Schwartz, A. S. Oswald, T. Y. Shen, M. Kinter, G. Tang and K. Zeller. 1988. Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphatase contains galac- tosamine and D-chiroinositol. Biochem. Biophys. Res. Commun. 151, 1416-1426
Lee, D. T. and W. Y. Lee. 2005. Effect of pinitol supplementation and strength training on anaerobic performance and status of energy substrates in healthy young men. Nutr. Sci. 8, 189-195
Narayanan, C. R., D. D. Joshi, A. M. Mujumdar and V. V. Dhekne. 1987. Pinitol？ a new anti-diabetic compound from the leaves of Bougainvillea spectabilis. Curr. Sci. 56, 139-141
Ortmeyer, H. K., N. L. Bodkin, K. Lilley and J. Larner. 1993. Chiroinositol deficiency and insulin resistance. I. Urinary excretion rate of chiroinositol is directly associated insulin resistance in spontaneously diabetic rhesus monkeys. Endocrinology 132, 640-645
Ortmeyer, H. K., L. C. Huang, H. L. Zhang, B. C. Hansen and J. Larner. 1993. Chiroinositol deficiency and insulin resistance. II. Acute effect of chiroinositol administration in streptozotocin-diabetic rats, normal rats given a glucose load, and spontaneously insulin-resistance in spontaneously diabetic rhesus monkeys. Endocrinology 132, 646-651
Ortmeyer, H. K., J. Larner and B. C. Hansen. 1995. Effects of D-chiroinositol added to a meal on plasma glucose and insulin in hyperinsulinemic rhesus monkeys. Obesity Res. 3, S605-S608
Park, J. Y., K. J. Kim, J. H. Lee, K. P. Lee and M. K. Kim. 2005. Effect of feeding chitosan, Hibiscus extract and L-carnitine mixture on body weight and lipid metabolism in rats. Kor. J. Food Culture 20, 194-204
Pak, Y., Y. Hong, S. Kim, T. Piccariello, R. V. Farese and J. Larner. 1998. In vivo chiro- inositol metabolism in rat: A defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro- [3H]inositol into phospholipids in the Goto-Kakizaki (G. K.) rat. Mol. Cells 8, 301-309
Pak, Y., L. C. Huang, K. J. Lilley and J. Larner. 1992. In vivo conversion of [ $^{3}H$ ]myo- inositol to [ $^{3}H$ ]chiro-inositol in rat tissue. J. Biol. Chem. 267, 16904-16910
Sethi, G., K. S. Ahn, B. Sung and B. B Aggarwal. 2008. Pinitol targets nuclear factor-kB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis. Mol. Cancer Ther. 7, 1604-1614
Sia, C. 2004. Spotlight on ethnomedicine: Usability of Sutherlandia flutescens in the treatment of diabetes. Rev. Diabetic Stud. 1, 145-149
Sohn, J. E., H. J. Koo and D. T. Lee. 2005. The effect of pinitol supplementation and resistance exercise on blood glucose level, physical characteristics, and physical fitness in elderly. Kor. J. Sports Nutr. 9, 189-194
Suzuki, S., Y. Taneda, S. Hirasi, S. Abe, A. Sasaki, K. Suzuki and T. Toyata. 1991. pp. 197-203, Molecular mechanism of insulin resistance in spontaneous diabetic GK (Goto-Kakizaki) rats. New Directions in Research and Clinical Works for Obesity and Diabetes Mellitus, Elsevier Science Publishers
Suzuki, S. and T. Toyota. 1994. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. Diabetes Care 17, 1465-1468
Viollet, B., R. Mounier, J. Leclerc, A. Yazigi, M. Foretz and F. Andreelli. 2007. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders. Diabetes Metab. 33, 395-402
Zhan, T. and L. Hongxiang. 2007. Synthesis of azole nucleoside analogues of D-pinitol as potential antitumor agents. Carbohydrate Res. 342, 865-869
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.